Accelerating
biomaterial innovation
from lab to market
About
Takara Medical is a MedTech engineering company bringing innovations from the lab to the customers.
At Takara, we accelerate the development of biomaterials and biopolymers for innovative medical devices through offering collaborations that reduce friction among early research, technical validation, regulatory planning, and international market access.
Our value proposition is to combine regulatory framework, testing, and market strategy in the development process to address developers and innovators through a strategic and technical collaboration.
Takara Medical connects Latin American innovation demand and biomaterial supply with Estonian and European research ecosystems, while opening commercialization pathways for biotech products across both regions.
The problem
Takara Medical addresses the problem of cellular proliferation and migration in regenerative medicine with innovative technology.
Our technology has high potential for healthy cell growth due to the biodegradability of the material that is optimised for maximum performance by providing nutrients to the growth environment and a breathable strong structure that facilitates cell migration throughout the entire regenerative process.
Team
Anna-Liisa Kubo, PhD
Chief Innovation Officer, CEO
Andrés Briceño Diaz
Chief Business Officer
Technology
& Products
Our mission is to provide plant‑based, animal‑free biopolymers and validation kits that shorten R&D cycles for skin health, wound care, and regenerative medicine product developers—combining high-standard design and manufacturing with cost‑efficient testing.